Cardio-oncology in China

被引：1

作者：

Sharma, K. ^{[1
]}

Wang, Shanshan ^{[1
]}

Liu, Ying ^{[2
]}

Zhang, Yangli ^{[2
]}

Liu, Tong ^{[3
]}

Zhang, Qingling ^{[3
]}

Zhong, Qiaoqing ^{[4
,5
]}

机构：

[1] Official Cardiooncol Org China, Rainbow Ctr, CardioOncol, 201 Floor 2,Bldg B,Hechuan Rd 3051, Shanghai 201100, Peoples R China

[2] Dalian Med Univ, Dept Cardiol, Affiliated Hosp 1, 193 United Rd, Dalian 116021, Liaoning, Peoples R China

[3] Second Hosp Tianjin Med Univ, Tianjin Inst Cardiol, Dept Cardiol, Tianjin Key Lab Ion Mol Funct Cardiovasc Dis, 23 Pingjiang Rd, Tianjin 300211, Peoples R China

[4] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia, Crit Care & Pain Med Dept, Boston, MA 02215 USA

[5] Cent South Univ, Xiangya Hosp, Dept Cardiovasc Med, Changsha 410008, Peoples R China

来源：

CURRENT TREATMENT OPTIONS IN ONCOLOGY | 2023年 / 24卷 / 10期

关键词：

Cardio-oncology; Multidisciplinary team; Evolvement of cardio-oncology; Knowledge Transfer Model; China;

D O I：

10.1007/s11864-023-01123-x

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Opinion statementCardio-oncology is going under rapid development in various areas across an increasing number of provinces in China. However there are still a myriad of challenges that need to be overcome in order to ensure its gradual and consistent expansion. The Cardio-Oncology Knowledge Transfer Model (KTM) forms the basis to allow exponential development of effective cardio-oncology services. This would ensure the implementation of precision-based practice while dynamically evolving cardio-oncology to integrate both Western and Chinese medical practices to become an official clinical sub-speciality in its own right in China, for the ultimate benefit of the patient.

引用

页码：1472 / 1488

页数：17

共 50 条

[1] Cardio-oncology in China
K. Sharma
Shanshan Wang
Ying Liu
Yangli Zhang
Tong Liu
Qingling Zhang
Qiaoqing Zhong
[J]. Current Treatment Options in Oncology, 2023, 24 : 1472 - 1488
[2] Cardio-Oncology in China We Are on the Go!
Zhang, Yuhui
Zhang, Zhiren
Liu, Ying
Zhang, Jian
[J]. JACC: CARDIOONCOLOGY, 2020, 2 (01): : 139 - 143
[3] Cardio-Oncology
Rayson, Daniel
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (26) : 2962 - +
[4] Cardio-Oncology: Mechanisms, Drug Combinations, and Reverse Cardio-Oncology
Liang, Zehua
He, Yuquan
Hu, Xin
[J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (18)
[5] Cardio-oncology
Ghosh, Arjun K.
Walker, J. Malcolm
[J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2017, 78 (01) : C11 - C13
[6] Working Together to Advance Cardio-Oncology in China
Xia, Yunlong
Liu, Jiwei
[J]. JACC: CARDIOONCOLOGY, 2020, 2 (01): : 144 - 145
[7] Emergence, Development, and Future of Cardio-Oncology in China
Liu, Ying
Zhang, Yan-Li
Liu, Ji-Wei
Fang, Feng-Qi
Li, Jian-Ming
Xia, Yun-Long
[J]. CHINESE MEDICAL JOURNAL, 2018, 131 (21) : 2640 - +
[8] Emergence, Development, and Future of Cardio-Oncology in China
Liu Ying
Zhang Yan-Li
Liu Ji-Wei
Fang Feng-Qi
Li Jian-Ming
Xia Yun-Long
[J]. 中华医学杂志(英文版), 2018, (21) : 2640 - 2644
[9] The ESC 2022 Cardio-Oncology Guidelines and the Road Ahead in Cardio-Oncology
Cheng, Richard K.
Ky, Bonnie
[J]. JACC: CARDIOONCOLOGY, 2023, 5 (01): : 131 - 132
[10] Interventional Cardio-Oncology: Adding a New Dimension to the Cardio-Oncology Field
Liu, Victor Y.
Agha, Ali M.
Lopez-Mattei, Juan
Palaskas, Nicolas
Kim, Peter
Thompson, Kara
Mouhayar, Elie
Marmagkiolis, Konstantinos
Hassan, Saamir A.
Karimzad, Kaveh
Iliescu, Cezar A.
[J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2018, 5

← 1 2 3 4 5 →